←
Gherman Novakovsky (слава Україні! 🇺🇦)802 posts
Gherman Novakovsky (слава Україні! 🇺🇦) avatar

Gherman Novakovsky (слава Україні! 🇺🇦)

@NovakovskyG

PhD, Illumina AI lab; interested in Deep Learning and genome regulation; also drawing, martial arts, guitar, and death metal! (he/him)

◷ Joined January 2018▧ 23 Photos and videos
Shiron Drusinsky avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Shiron Drusinsky@Shirondrusinsky·21h

1/ I’m thrilled to share a new preprint, where we investigate how long-range sequence-to-function (S2F) models like Enformer, Borzoi and AlphaGenome learn variant effects during post-training: biorxiv.org/content/10.64898…

Adam He avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Adam He@missing_a_rib·Nov 11

A quick code drop: I ported Illumina’s PromoterAI from Tensorflow/Keras to PyTorch (github.com/adamyhe/promotera…). I actually wrote about this on the genomicsxai blog a couple months ago (genomicsxai.github.io/blogs/…). This week, I added two major optimizations.

Sushmita Roy @sroyyors.bsky.social,genomic.social avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Sushmita Roy @sroyyors.bsky.social,genomic.social@sroyyors·Oct 25

nature.com/articles/s41588-0… Timely review on leveraging deep learning methods for predicting effects of non-coding variants.

Anshul Kundaje avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Anshul Kundaje@anshulkundaje·Oct 20

Cell-state conditioned sequence model of chromatin & expression trained jointly across diverse cell contexts by @zhou_jingtian & colleagues. Nice addition to the growing collection of joint cis-trans models of gene regulation. Still lots to do make the trans component causal.

Our cells carry the same DNA, but how this DNA is interpreted differs wildly from cell to cell. In a new preprint, Science Fellow @zhou_jingtian and team introduce Bolero, a model conditioned on cell state that predicts chromatin accessibility and expression from DNA alone.

Post attachment
Anshul Kundaje avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Anshul Kundaje@anshulkundaje·Oct 15

This work is not getting enough attention. These are pretty massive leaps in modeling splicing. Very excited about this. Need to do a deep read but the performance on diverse splicing related tasks looks really good.

#SpliceAI2 splice variant effect benchmarks. Considerably improved performance in 9 evaluations spanning cryptic splicing, sQTLs, MPRAs, population genetics, plasma proteins, and rare disease. 🧬✂️🧵

Post attachment
Xiangmeng(Shawn) Cai avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Xiangmeng(Shawn) Cai@XiangmengCai·Oct 9

Have you ever looked at a gene in IGV or a genome browser and wondered “What are all those (ATAC-seq/H3K27ac/CTCF ChIP-seq/…) peaks doing?” 🤔 I’m thrilled to share that we developed a new technology called Swap-seq to answer that exact question. biorxiv.org/content/10.64898…

Jeff Vierstra avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Jeff Vierstra@jeffvierstra·Oct 8

Just put the finishing touches on this beast. 17yrs to get here and the largest, most information dense dataset I had the privilege to generate and analyze. Look for it on bioRxiv next week!

Post attachment
David Kelley avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
David Kelley@drklly·Oct 9

This week we're releasing a preprint exploring state space models for long-sequence genomic prediction, alongside Cerberus, a set of open PyTorch models built on this work. biorxiv.org/content/10.64898…

Illumina avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Illumina@illumina·Oct 8

Illumina's genomic AI models now enable researchers to identify 2x as many variants with predicted biological impact. Identifying these variants and understanding their downstream effects can unlock new biological insights to advance rare disease and drug discovery research. The newest generation of our leading-edge genomic AI models are designed to help researchers assess the functional impact of splice, promoter, and missense variants. With SpliceAI2, out today, we aim to help researchers advance rare disease research. In the words of the vice president of BioInsight AI Lab, Kyle Farh: “Illumina is advancing AI to systematically shrink the portion of the genome that remains uninterpretable.” 🔗 Learn more: assets.illumina.com/content/… For Research Use Only. Not for use in diagnostic procedures.

Post attachment
Jianbin Chen avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Jianbin Chen@Bright_88·Oct 8

Super excited to share SpliceAI2! ✂️🧬 It predicts splice-site and splice-junction usage, reconstructs complete transcripts, and models tissue- and disease-specific splicing. Proud to have contributed, and huge credit to the incredible team behind it! Check out the tweetorial!⬇️

Incredibly, incredibly excited to introduce SpliceAI2, the next generation of splicing prediction! 🧬🚀🧵

0:30
Kishore Jaganathan avatar
⟳ Gherman Novakovsky (слава Україні! 🇺🇦) retweeted
Kishore Jaganathan@kjaganatha·Oct 8

Incredibly, incredibly excited to introduce SpliceAI2, the next generation of splicing prediction! 🧬🚀🧵

0:30